menu
    • menu

    Company profile for Ray Therapeutics

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ray Therapeutics is developing novel optogenetics gene therapies for patients with blinding diseases. The company is developing its lead candidate Ray-001 in retinitis pigmentosa, a degenerative retinal disease with significant unmet medical need. The company’s mission is to use optogenetics to restore vision, independent of genetic mutation for patients with inherited retinal diseases. Ray Therapeutics is based in San Diego...
    Ray Therapeutics is developing novel optogenetics gene therapies for patients with blinding diseases. The company is developing its lead candidate Ray-001 in retinitis pigmentosa, a degenerative retinal disease with significant unmet medical need. The company’s mission is to use optogenetics to restore vision, independent of genetic mutation for patients with inherited retinal diseases. Ray Therapeutics is based in San Diego, CA. Restore vision in patients with retinitis pigmentosa and other degenerative retinal diseases with our novel optogenetics approach.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ray TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    San Diego, California
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://raytherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ray-therapeutics-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ray Shines A Light On $125M Round Targeting Genetic Eye Therapy
    Ray Shines A Light On $125M Round Targeting Genetic Eye Therapy

    21 Apr 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/ray-therapeutics-shines-light-125m-round-targeting-genetic-eye-therapy

    FIERCE BIOTECH
    21 Apr 2026
    Share Share
    Ray Therapeutics Gets FDA (RMAT) Designation For RTx-015
    Ray Therapeutics Gets FDA (RMAT) Designation For RTx-015

    01 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-01/ray-therapeutics-receives-fda-regenerative-medicine-advanced-therapy-rmat-designation-for-rtx-015

    PHARMIWEB
    01 Apr 2026
    Share Share
    Ray Therapeutics Names Michael Murtagh Chief Regulatory Officer
    Ray Therapeutics Names Michael Murtagh Chief Regulatory Officer

    17 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260217093339/en/Ray-Therapeutics-Appoints-Michael-Murtagh-as-Chief-Regulatory-Officer

    BUSINESSWIRE
    17 Feb 2026
    Share Share
    Ray Therapeutics Names Scott Braunstein as Chairman Of Board
    Ray Therapeutics Names Scott Braunstein as Chairman Of Board

    08 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260108146385/en/Ray-Therapeutics-Appoints-Scott-Braunstein-M.D.-as-Chairman-of-the-Board-of-Directors

    BUSINESSWIRE
    08 Jan 2026
    Share Share
    Ray Therapeutics gets $8M CIRM grant for RTx-015 gene therapy
    Ray Therapeutics gets $8M CIRM grant for RTx-015 gene therapy

    24 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250423701322/en/Ray-Therapeutics-Awarded-%248M-CIRM-Grant-to-Advance-RTx-015-Gene-Therapy-for-Retinitis-Pigmentosa

    BUSINESSWIRE
    24 Apr 2025
    Share Share
    Terray Therapeutics Closes $120M Series B For AI Drug Pipeline
    Terray Therapeutics Closes $120M Series B For AI Drug Pipeline

    17 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241017147331/en

    BUSINESSWIRE
    17 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search